Federal solicitation · SPE2D2-26-D-0001 · back to recent
Potassium Chloride Extended Release Tablets
DEPT OF DEFENSE · NAICS 325412 · NONE · $39.5M est.
Solicitation description
SPE2D2-26-D-0001 Potassium Chloride ER Tablets
Related Market Brief signals
-
2026-W11
· large_dollar_dept_of_defense_325412
$39.5M estimated value. Potassium Chloride Extended Release Tablets
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Febuxostat National Contract | DEPT OF DEFENSE | $73.4M | same agency naics |
| Telmisartan Tablets | DEPT OF DEFENSE | $64.6M | same agency naics |
| Estradiol Tablets | DEPT OF DEFENSE | $43.1M | same agency naics |
| Ziprasidone Capsules | DEPT OF DEFENSE | $36.3M | same agency naics |
| Hydrocodone Acetaminophen | DEPT OF DEFENSE | $29.3M | same agency naics |
| FINASTERIDE TABLETS | DEPT OF DEFENSE | $29.0M | same agency naics |
| Omeprazole Capsules | DEPT OF DEFENSE | $28.8M | same agency naics |
| Lisinopril HCTZ | DEPT OF DEFENSE | $28.2M | same agency naics |
Data this profile does NOT cover
- No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.
- No FPDSAward rows for NAICS 325412 in the trailing 12 months; vendor concentration unavailable.